Patient Dropouts

• 

  Subject Areas on Research

  • A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial. 
  • A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. 
  • A motivational intervention can improve retention in PCIT for low-motivation child welfare clients. 
  • A prospective study of the modified Atkins diet for intractable epilepsy in adults. 
  • A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period. 
  • A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. 
  • Anaemia of CKD--the CHOIR study revisited. 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. 
  • Benefits of Treatment Completion Over Premature Termination: Findings from the National Child Traumatic Stress Network. 
  • Cognitive and affective predictors of treatment outcome in Cognitive Processing Therapy and Prolonged Exposure for posttraumatic stress disorder. 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. 
  • Comparison of academic and nonacademic sites in multi-center clinical trials. 
  • Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study. 
  • Comparison of spouse and nonkin controls: the experience of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 
  • Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). 
  • Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. 
  • Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. 
  • Determinants of attrition in a natural history study of Alzheimer disease. 
  • Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. 
  • Double-blind randomized study comparing brand-name and generic phenytoin monotherapy. 
  • Effect of dropouts on sample size estimates for test on trends across repeated measurements. 
  • Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. 
  • Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. 
  • Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. 
  • Effects of exercise on plasma lipoproteins. 
  • Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. 
  • Electroconvulsive therapy is equally effective in unipolar and bipolar depression. 
  • Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. 
  • Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. 
  • Exercise adherence and 10-year mortality in chronically ill older adults. 
  • Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. 
  • Factors Associated With Attrition in Randomized Controlled Trials of Vocal Rehabilitation: Systematic Review and Meta-Analysis. 
  • General practice orthopaedic outpatient referrals in North Staffordshire. 
  • HIV-related stigma among an urban sample of persons living with HIV at risk for dropping out of HIV-oriented primary medical care. 
  • High rates of PTSD treatment dropout: A possible red herring? 
  • High- and low-structure treatments for substance dependence: role of learned helplessness. 
  • Hypertension control in a rural southern community: medical care process and dropping out. 
  • Impact of depressive symptoms on the treatment of generalized social anxiety disorder. 
  • Impact of race on early treatment termination and outcomes in posttraumatic stress disorder treatment. 
  • Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). 
  • Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. 
  • Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical Trials. 
  • Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. 
  • Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis. 
  • One or two session psychotherapy with university students. 
  • Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. 
  • Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. 
  • Predictors of attendance and dropout in three randomized controlled trials of PTSD treatment for active duty service members. 
  • Predictors of attrition from a clinical pediatric obesity treatment program. 
  • Predictors of treatment engagement in ethnically diverse, urban children receiving treatment for trauma exposure. 
  • Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT. 
  • Progression of Alzheimer's disease in black and white patients: the CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease. 
  • Randomization in clinical trials. 
  • Recruitment and retention: A randomized controlled trial of video-enhanced versus standard consent processes within the E-OPTIMAL study. 
  • Recruitment of African American women to a walking program: eligibility, ineligibility, and attrition during screening. 
  • Risk status for dropping out of developmental followup for very low birth weight infants. 
  • Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. 
  • Single-session psychotherapy. 
  • Study refusal and exclusion from a randomized treatment study of generalized social phobia. 
  • The Edgecombe County High Blood Pressure Control Program: III. Social support, social stressors, and treatment dropout. 
  • The Gerofit Program: a VA innovation. 
  • The behavioral control of obesity: a descriptive analysis of a large-scale program. 
  • The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. 
  • The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. 
  • The impact of childhood abuse among women with assault-related PTSD receiving short-term cognitive-behavioral therapy. 
  • The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. 
  • Time course of treatment dropout in cognitive-behavioral therapies for posttraumatic stress disorder. 
  • Using observational data to estimate prognosis: an example using a coronary artery disease registry. 
  • Wechsler Memory Scale Scores, selective attrition, and distance from death. 
  • Weight reduction at the work site: a promise partially fulfilled. 
  • Working at a loss: Implications of loss to follow up for treatment effect estimation in randomised controlled trials. 
• 

  Keywords of People

  • McClintock, Shawn Michael, Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Brain Stimulation and Neurophysiology
  • Yancy Jr., William Samuel, Associate Professor of Medicine, Medicine, General Internal Medicine